Right to Try for Individualized Treatments Act

This bill, known as the Right to Try for Individualized Treatments Act, allows patients with life-threatening diseases or severe illnesses to access experimental drugs tailored to their unique genetic makeup. To qualify, a patient must have exhausted approved treatment options and receive a physician's certification that standard therapies are unlikely to help, along with written informed consent. The legislation permits manufacturers to offer these personalized treatments without requiring them to prove safety or efficacy, provided the process occurs within an eligible healthcare facility. Importantly, the bill does not mandate that manufacturers provide these treatments, leaving the decision to make them available entirely up to the drug producers.